from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0009/ppiA

LFCtreatmentdescriptionclass of inhibitor

0.225

Amikacinug/mL Amikacintranslation

0.080

Cap5-10ug/mL Capreomycintranslation

0.014

Rox10-50 ug/mL Roxithromycintranslation

0.648

SM2-5 ug/mL Streptomycintranslation

-1.142

Tet5-10 ug/mL Tetracyclinetranslation

-1.415

Rif0.2-5ug/mL Rifampicintranscription

-0.043

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.390

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.799

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.910

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.555

Clofazimine10-13 ug/mL Clofaziminerespiration

0.253

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.662

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.379

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.049

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.441

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.939

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.458

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.122

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.285

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.829

KCN5-20 ug/mL Potassium cyaniderespiration

0.310

NaN30.2-2 mM Sodium aziderespiration

0.879

Nigericin50 uM Nigericinrespiration

-0.896

TRC10-150 ug/mL Triclosanrespiration

-1.849

TRZ10-25 ug/mL Thioridazinerespiration

-1.440

Valinomycin0.5-10 uM Valinomycinrespiration

0.725

ZnSO42 mM ZnSO4respiration

0.174

menadione6-10 ug/mL Menadionerespiration

-1.107

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.510

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.064

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.901

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.276

NRP_1Non-replicating persistence stage 1dosRassociated

0.787

Amp0.2mg/mL AmpicillincellWall

0.416

Cephalexin20-100 ug/mL CephalexincellWall

0.929

Cerulenin0.32-5 ug/mL CerulenincellWall

0.743

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.704

EMB10-20 ug/mL EthambutolcellWall

1.095

Eta12-40 ug/mL EthionamidecellWall

1.136

INH0.2-0.4 ug/mL IsoniazidcellWall

0.813

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.778

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.583

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.207

BZA0.12 mg/mL BenzamidearomaticAmides

0.153

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.144

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.355

H2O24 mM hydrogen peroxideDNAdamaging

0.193

Levo10 ug/mL LevofloxacinDNAdamaging

0.709

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.100

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.836

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.980

UVUV-irradiationDNAdamaging

-1.719

ARP41-4 ug/mL Antitubercular compound ARP4?

0.678

Antimycin12.5-50 ug/mL Antimycin A?

0.676

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.413

PA_110-50 ug/mL Antitubercular compound PA-1?

0.563

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.025

PA8240.2-2 ug/mL PA-824?

-0.510

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.199

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.595

Verapamil50 uM Verapamil?

0.932

mercaptoethanol2 mM 2-Mercaptoethanol?

0.850

methoxatin10-20 ug/mL Methoxatin?